Hyperion DeFi, Inc.(HYPD)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | Jung Hyunsu See Remarks | Purchase | +8,000 | +1.92%425,676 | $3.70 | $29,580 | View SEC filing | |
| 2026-01-05 | Knox David R. Chief Financial Officer | Purchase | +27,950 | +9.32%327,950 | $3.59 | $100,341 | View SEC filing | |
| 2025-12-30 | Strahlman Ellen R Director | Purchase | +30,880 | +32.45%126,030 | $3.66 | $113,091 | View SEC filing | |
| 2025-12-22 | Strahlman Ellen R Director | Purchase | +38,444 | +29.09%170,598 | $3.14 | $120,664 | View SEC filing | |
| 2025-12-19 | Walters Happy David Director | Purchase | +61,930 | +123.86%111,930 | $3.02 | $187,152 | View SEC filing | |
| 2025-12-19 | GELTZEILER MICHAEL S Director | Purchase | +30,000 | +51.71%88,015 | $3.01 | $90,210 | View SEC filing | |
| 2024-08-28 | Rowe Michael M Chief Executive Officer | Purchase | +27,071 | +32.64%109,998 | $0.52 | $14,077 | View SEC filing | |
| 2024-08-27 | Rowe Michael M Chief Executive Officer | Purchase | +50,000 | +151.85%82,927 | $0.57 | $28,500 | View SEC filing | |
| 2024-07-03 | Grant Stuart M. 10% Owner | Purchase | +1,515,151 | +16.12%10,914,153 | $0.66 | $1,000,000 | View SEC filing | |
| 2024-03-28 | Grant Stuart M. 10% Owner | Purchase | +100,000 | +1.88%5,430,715 | $0.98 | $98,000 | View SEC filing | |
| 2024-03-20 | Grant Stuart M. 10% Owner | Purchase | +50,000 | +0.95%5,330,715 | $1.23 | $61,500 | View SEC filing | |
| 2024-03-11 | Grant Stuart M. 10% Owner | Purchase | +10,717 | +0.20%5,280,715 | $1.58 | $16,911 | View SEC filing | |
| 2023-12-05 | Rowe Michael M Chief Executive Officer | Purchase | +4,890 | +17.44%32,927 | $1.36 | $6,650 | View SEC filing | |
| 2023-10-02 | Strahlman Ellen R Director | Purchase | +4,820 | +6.86%75,113 | $1.68 | $8,098 | View SEC filing | |
| 2023-09-19 | Rowe Michael M Chief Executive Officer | Purchase | +2,537 | +9.95%28,037 | $1.70 | $4,314 | View SEC filing | |
| 2023-08-17 | Grant Stuart M. 10% Owner | Purchase | +75,000 | +1.44%5,269,998 | $1.89 | $141,915 | View SEC filing | |
| 2023-05-31 | GANDOLFO JOHN P Chief Financial Officer | Purchase | +2,000 | +33.33%8,000 | $2.79 | $5,580 | View SEC filing | |
| 2023-05-31 | Kern Bren Chief Operating Officer | Purchase | +2,500 | +100.00%2,500 | $2.73 | $6,825 | View SEC filing | |
| 2023-05-30 | MATHER CHARLES E IV Director | Purchase | +3,000 | +4.02%77,544 | $2.49 | $7,470 | View SEC filing | |
| 2023-05-26 | Grant Stuart M. 10% Owner | Purchase | +88,247 | +1.73%5,194,998 | $2.65 | $233,855 | View SEC filing | |
| 2023-05-25 | Strahlman Ellen R Director | Purchase | +10,000 | +23.23%53,052 | $3.10 | $30,976 | View SEC filing | |
| 2023-05-16 | MATHER CHARLES E IV Director | Purchase | +4,000 | +5.67%74,544 | $3.39 | $13,560 | View SEC filing | |
| 2023-05-16 | MATHER CHARLES E IV Director | Purchase | -4,000 | -5.09%74,544 | $3.39 | $13,560 | View SEC filing | |
| 2023-05-02 | Ianchulev Tsontcho Director | Sale | -90,000 | -21.37%331,211 | $5.50 | $495,000 | View SEC filing | |
| 2023-05-01 | Ianchulev Tsontcho Director | Sale | -60,000 | -12.47%421,211 | $5.00 | $300,000 | View SEC filing |
1-25 of 78